SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Haolin Ni who wrote (631)5/5/1998 8:51:00 AM
From: charles sims  Read Replies (1) of 2135
 
the major question is mode of delivery The key player here will be robert langer head of chem engineering at MIT who was a former researcher in folkman's lab. would look into the several companies focused on depo release of drugs this should be the next market to move since as/es will need a carrier to be delivered to the tumor. From what i have seen in some of the early experiments this is the real deal neutral observer just wished that i had thought about the combination before folkman but that research.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News